Simplify Opportunistic Income ETF

CRDT · ETF

$20.84+$0.2852 (+1.39%)TodayMarket closed ·
Prev close $20.55

About CRDT

CRDT was created on 2023-06-26 by Simplify. The fund's investment portfolio concentrates primarily on broad credit fixed income. The ETF currently has 26.31m in AUM and 41 holdings. CRDT is an actively managed fund that holds various fixed income securities from developed markets. The fund has no maturity and credit rating limitation. The fund aims to provide current income, long-term capital appreciation is a secondary objective.

Issuer
Simplify
Expense ratio
0.99%
Assets under management
$27.36M
Inception
Jun 26, 2023
Asset class
Fixed Income

CRDT key statistics

Price-earnings ratio
0.00
Average volume
7.62K
Volume
9.82K
Open price
$20.82
High today
$20.84
Low today
$20.71
52 Week high
$23.98
52 Week low
$19.94

Simplify Opportunistic Income ETF (CRDT) at a glance

Simplify Opportunistic Income ETF (CRDT) last traded at $20.84, with a price-to-earnings ratio of 0.00.

Today the fund has traded between $20.71 and $20.84. The current price is 0.6% above the day's low and 0.0% below its high.

Volume so far is 9.82K shares, above the average of 7.62K shares a day.

Over the past year Simplify Opportunistic Income ETF has ranged from $19.94 to $23.98, and now sits 22% of the way up that range.

CRDT news

  • Press releaseBusiness Wire

    Simplify Provides Estimated Capital Gain Distribution Information for 2025

  • Press releaseBusiness Wire

    Simplify Provides Estimated Capital Gain Distribution Information for 2024

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.